CSFB scores second healthcare deal in two days

Credit Suisse First Boston is advising Zimmer, the US orthopaedics company, on a Sfr4.16bn (€2.75bn) offer for Swiss rival Centerpulse, giving the bank's healthcare team its second transatlantic deal in two days.

On Monday CSFB advised PowderJect Pharmaceuticals in the UK on its proposed £542m (€759m) takeover by Chiron, the US pharmaceuticals company. A spokesman for Zimmer confirmed that CSFB, which is not a retained adviser to the company, was hired to advise on the Centerpulse deal because of the strength of its healthcare team.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump